Molecular Pathology

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Valentinis, B
Right arrow Articles by Baserga, R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Valentinis, B
Right arrow Articles by Baserga, R
J Clin Pathol: Mol Pathol 2001; 54:133-137
© 2001 Journal of Clinical Pathology


Review

IGF-I receptor signalling in transformation and differentiation

B Valentinis and R Baserga

Kimmel Cancer Center, Thomas Jefferson University, 233 S. 10th Street, 624 BLSB, Philadelphia, PA 19107, USA

Correspondence: Dr Baserga r_baserga{at}lac.jci.tju.edu

The type 1 insulin-like growth factor receptor (IGF-IR) sends several signals, some of which are contradictory. When the concentrations of insulin receptor substrate 1 (IRS-1), a major substrate of the IGF-IR, are high, the signal is mitogenic, anti-apoptotic, and can even cause malignant transformation. However, in the absence of IRS-1, the IGF-IR sends a differentiation signal, which leads to granulocytic differentiation in haemopoietic cells. The mitogenic signal of the IGF-IR/IRS-1 combination depends largely, but not exclusively, on the activation of the phosphatidylinositol-3 kinase (PI3K).

Key Words: insulin-like growth factor 1 receptor • differentiation • insulin receptor substrate 1 • transformation




This article has been cited by other articles:


Home page
Ann OncolHome page
C. Braconi, R. Bracci, I. Bearzi, F. Bianchi, S. Sabato, A. Mandolesi, L. Belvederesi, S. Cascinu, N. Valeri, and R. Cellerino
Insulin-like growth factor (IGF) 1 and 2 help to predict disease outcome in GIST patients
Ann. Onc., July 1, 2008; 19(7): 1293 - 1298.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. M. Kavurma, M. Schoppet, Y. V. Bobryshev, L. M. Khachigian, and M. R. Bennett
TRAIL Stimulates Proliferation of Vascular Smooth Muscle Cells via Activation of NF-{kappa}B and Induction of Insulin-like Growth Factor-1 Receptor
J. Biol. Chem., March 21, 2008; 283(12): 7754 - 7762.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Ravikumar, G. Perez-Liz, L. Del Vale, D. R. Soprano, and K. J. Soprano
Insulin Receptor Substrate-1 Is an Important Mediator of Ovarian Cancer Cell Growth Suppression by All-trans Retinoic Acid
Cancer Res., October 1, 2007; 67(19): 9266 - 9275.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Frasca, G. Pandini, R. Malaguarnera, A. Mandarino, R. L. Messina, L. Sciacca, A. Belfiore, and R. Vigneri
Role of c-Abl in Directing Metabolic versus Mitogenic Effects in Insulin Receptor Signaling
J. Biol. Chem., September 7, 2007; 282(36): 26077 - 26088.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Yan, C.-T. Yu, M. Ozen, M. Ittmann, S. Y. Tsai, and M.-J. Tsai
Steroid Receptor Coactivator-3 and Activator Protein-1 Coordinately Regulate the Transcription of Components of the Insulin-Like Growth Factor/AKT Signaling Pathway.
Cancer Res., November 15, 2006; 66(22): 11039 - 11046.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Aiello, G. Pandini, F. Frasca, E. Conte, A. Murabito, A. Sacco, M. Genua, R. Vigneri, and A. Belfiore
Peroxisomal Proliferator-Activated Receptor-{gamma} Agonists Induce Partial Reversion of Epithelial-Mesenchymal Transition in Anaplastic Thyroid Cancer Cells
Endocrinology, September 1, 2006; 147(9): 4463 - 4475.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
C. Z. Michaylira, J. G. Simmons, N. M. Ramocki, B. P. Scull, K. K. McNaughton, C. R. Fuller, and P. K. Lund
Suppressor of cytokine signaling-2 limits intestinal growth and enterotrophic actions of IGF-I in vivo
Am J Physiol Gastrointest Liver Physiol, September 1, 2006; 291(3): G472 - G481.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Li and W. T. Miller
Role of the Activation Loop Tyrosines in Regulation of the Insulin-like Growth Factor I Receptor-tyrosine Kinase
J. Biol. Chem., August 18, 2006; 281(33): 23785 - 23791.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Z. Wang, G. Chakravarty, S. Kim, Y. D. Yazici, M. N. Younes, S. A. Jasser, A. A. Santillan, C. D. Bucana, A. K. El-Naggar, and J. N. Myers
Growth-Inhibitory Effects of Human Anti-Insulin-Like Growth Factor-I Receptor Antibody (A12) in an Orthotopic Nude Mouse Model of Anaplastic Thyroid Carcinoma
Clin. Cancer Res., August 1, 2006; 12(15): 4755 - 4765.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
F. Cappuzzo, L. Toschi, G. Tallini, G. L. Ceresoli, I. Domenichini, S. Bartolini, G. Finocchiaro, E. Magrini, G. Metro, A. Cancellieri, et al.
Insulin-like growth factor receptor 1 (IGFR-1) is significantly associated with longer survival in non-small-cell lung cancer patients treated with gefitinib
Ann. Onc., July 1, 2006; 17(7): 1120 - 1127.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
K. A. Kellar, M. V. Lorenzi, C. P. Ho, D. You, M.-L. Wen, R. P. Ryseck, S. Oppenheimer, B. E. Fink, G. D. Vite, B. R. Rowley, et al.
Constitutively active receptor tyrosine kinases as oncogenes in preclinical models for cancer therapeutics.
Mol. Cancer Ther., June 1, 2006; 5(6): 1571 - 1576.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. Sadagurski, S. Yakar, G. Weingarten, M. Holzenberger, C. J. Rhodes, D. Breitkreutz, D. LeRoith, and E. Wertheimer
Insulin-like growth factor 1 receptor signaling regulates skin development and inhibits skin keratinocyte differentiation.
Mol. Cell. Biol., April 1, 2006; 26(7): 2675 - 2687.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
T. Yamamoto, S. Oida, and T. Inage
Gene Expression and Localization of Insulin-like Growth Factors and Their Receptors throughout Amelogenesis in Rat Incisors
J. Histochem. Cytochem., February 1, 2006; 54(2): 243 - 252.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. Menu, H. Jernberg-Wiklund, T. Stromberg, H. De Raeve, L. Girnita, O. Larsson, M. Axelson, K. Asosingh, K. Nilsson, B. Van Camp, et al.
Inhibiting the IGF-1 receptor tyrosine kinase with the cyclolignan PPP: an in vitro and in vivo study in the 5T33MM mouse model
Blood, January 15, 2006; 107(2): 655 - 660.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Stromberg, S. Ekman, L. Girnita, L. Y. Dimberg, O. Larsson, M. Axelson, J. Lennartsson, U. Hellman, K. Carlson, A. Osterborg, et al.
IGF-1 receptor tyrosine kinase inhibition by the cyclolignan PPP induces G2/M-phase accumulation and apoptosis in multiple myeloma cells
Blood, January 15, 2006; 107(2): 669 - 678.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
C. Decraene, R. Benchaouir, M.-A. Dillies, D. Israeli, S. Bortoli, C. Rochon, P. Rameau, A. Pitaval, D. T.-L. Roux, O. Danos, et al.
Global transcriptional characterization of SP and MP cells from the myogenic C2C12 cell line: effect of FGF6
Physiol Genomics, October 17, 2005; 23(2): 132 - 149.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Osipo, K. Meeke, H. Liu, D. Cheng, S. Lim, A. Weichel, and V. C. Jordan
Trastuzumab Therapy for Tamoxifen-Stimulated Endometrial Cancer
Cancer Res., September 15, 2005; 65(18): 8504 - 8513.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. L. Goel, M. Breen, J. Zhang, I. Das, S. Aznavoorian-Cheshire, N. M. Greenberg, A. Elgavish, and L. R. Languino
{beta}1A Integrin Expression Is Required for Type 1 Insulin-Like Growth Factor Receptor Mitogenic and Transforming Activities and Localization to Focal Contacts
Cancer Res., August 1, 2005; 65(15): 6692 - 6700.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
M Koda, M Sulkowska, L Kanczuga-Koda, and S Sulkowski
Expression of insulin receptor substrate 1 in primary breast cancer and lymph node metastases
J. Clin. Pathol., June 1, 2005; 58(6): 645 - 649.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. D. Wu, A. Odman, L. M. Higgins, K. Haugk, R. Vessella, D. L. Ludwig, and S. R. Plymate
In vivo Effects of the Human Type I Insulin-Like Growth Factor Receptor Antibody A12 on Androgen-Dependent and Androgen-Independent Xenograft Human Prostate Tumors
Clin. Cancer Res., April 15, 2005; 11(8): 3065 - 3074.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Hintermann, N. Yang, D. O'Sullivan, J. M. G. Higgins, and V. Quaranta
Integrin {alpha}6{beta}4-erbB2 Complex Inhibits Haptotaxis by Up-regulating E-cadherin Cell-Cell Junctions in Keratinocytes
J. Biol. Chem., March 4, 2005; 280(9): 8004 - 8015.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
W. Ruan, M. E. Monaco, and D. L. Kleinberg
Progesterone Stimulates Mammary Gland Ductal Morphogenesis by Synergizing with and Enhancing Insulin-Like Growth Factor-I Action
Endocrinology, March 1, 2005; 146(3): 1170 - 1178.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
G. S. Warshamana-Greene, J. Litz, E. Buchdunger, C. Garcia-Echeverria, F. Hofmann, and G. W. Krystal
The Insulin-Like Growth Factor-I Receptor Kinase Inhibitor, NVP-ADW742, Sensitizes Small Cell Lung Cancer Cell Lines to the Effects of Chemotherapy
Clin. Cancer Res., February 15, 2005; 11(4): 1563 - 1571.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
C. S. Bickel, J. Slade, E. Mahoney, F. Haddad, G. A. Dudley, and G. R. Adams
Time course of molecular responses of human skeletal muscle to acute bouts of resistance exercise
J Appl Physiol, February 1, 2005; 98(2): 482 - 488.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. Ahlen, J. Wejde, O. Brosjo, A. von Rosen, W.-H. Weng, L. Girnita, O. Larsson, and C. Larsson
Insulin-Like Growth Factor Type 1 Receptor Expression Correlates to Good Prognosis in Highly Malignant Soft Tissue Sarcoma
Clin. Cancer Res., January 1, 2005; 11(1): 206 - 216.
[Abstract] [Full Text] [PDF]


Home page
Integr Cancer TherHome page
M. F. McCarty
Targeting Multiple Signaling Pathways as a Strategy for Managing Prostate Cancer: Multifocal Signal Modulation Therapy
Integr Cancer Ther, December 1, 2004; 3(4): 349 - 380.
[Abstract] [PDF]


Home page
EndocrinologyHome page
Y. Kaburagi, R. Yamashita, Y. Ito, H. Okochi, R. Yamamoto-Honda, K. Yasuda, H. Sekihara, T. Sasazuki, T. Kadowaki, and Y. Yazaki
Insulin-Induced Cell Cycle Progression Is Impaired in Chinese Hamster Ovary Cells Overexpressing Insulin Receptor Substrate-3
Endocrinology, December 1, 2004; 145(12): 5862 - 5874.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
A. Prieur, F. Tirode, P. Cohen, and O. Delattre
EWS/FLI-1 Silencing and Gene Profiling of Ewing Cells Reveal Downstream Oncogenic Pathways and a Crucial Role for Repression of Insulin-Like Growth Factor Binding Protein 3
Mol. Cell. Biol., August 15, 2004; 24(16): 7275 - 7283.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
H. L. Goel, M. Fornaro, L. Moro, N. Teider, J. S. Rhim, M. King, and L. R. Languino
Selective modulation of type 1 insulin-like growth factor receptor signaling and functions by {beta}1 integrins
J. Cell Biol., August 2, 2004; 166(3): 407 - 418.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
M. F McCarty
Insulin and IGF-I as determinants of low 'Western' cancer rates in the rural third world
Int. J. Epidemiol., August 1, 2004; 33(4): 908 - 910.
[Full Text] [PDF]


Home page
Physiol. GenomicsHome page
T. Tsuchiya, J. M. Dhahbi, X. Cui, P. L. Mote, A. Bartke, and S. R. Spindler
Additive regulation of hepatic gene expression by dwarfism and caloric restriction
Physiol Genomics, May 19, 2004; 17(3): 307 - 315.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
W.-F. Chen and M.-S. Wong
Genistein Enhances Insulin-Like Growth Factor Signaling Pathway in Human Breast Cancer (MCF-7) Cells
J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2351 - 2359.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
G. S. Warshamana-Greene, J. Litz, E. Buchdunger, F. Hofmann, C. Garcia-Echeverria, and G. W. Krystal
The insulin-like growth factor-I (IGF-I) receptor kinase inhibitor NVP-ADW742, in combination with STI571, delineates a spectrum of dependence of small cell lung cancer on IGF-I and stem cell factor signaling
Mol. Cancer Ther., May 1, 2004; 3(5): 527 - 536.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. Wessells, S. Yakar, and P. F. Johnson
Critical Prosurvival Roles for C/EBP{beta} and Insulin-Like Growth Factor I in Macrophage Tumor Cells
Mol. Cell. Biol., April 15, 2004; 24(8): 3238 - 3250.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Stromberg, A. Dimberg, A. Hammarberg, K. Carlson, A. Osterborg, K. Nilsson, and H. Jernberg-Wiklund
Rapamycin sensitizes multiple myeloma cells to apoptosis induced by dexamethasone
Blood, April 15, 2004; 103(8): 3138 - 3147.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Shimoaka, S. Kamekura, H. Chikuda, K. Hoshi, U.-i. Chung, T. Akune, Z. Maruyama, T. Komori, M. Matsumoto, W. Ogawa, et al.
Impairment of Bone Healing by Insulin Receptor Substrate-1 Deficiency
J. Biol. Chem., April 9, 2004; 279(15): 15314 - 15322.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. H. Shen, Y. Yin, S. R. Broussard, R. H. McCusker, G. G. Freund, R. Dantzer, and K. W. Kelley
Tumor Necrosis Factor {alpha} Inhibits Cyclin A Expression and Retinoblastoma Hyperphosphorylation Triggered by Insulin-like Growth Factor-I Induction of New E2F-1 Synthesis
J. Biol. Chem., February 27, 2004; 279(9): 7438 - 7446.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. X. Song, C. J. Barnes, Z. Zhang, Y. Bao, R. Kumar, and R. J. Santen
The role of Shc and insulin-like growth factor 1 receptor in mediating the translocation of estrogen receptor {alpha} to the plasma membrane
PNAS, February 17, 2004; 101(7): 2076 - 2081.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Ahmad, G. Farnie, N. J. Bundred, and N. G. Anderson
The Mitogenic Action of Insulin-like Growth Factor I in Normal Human Mammary Epithelial Cells Requires the Epidermal Growth Factor Receptor Tyrosine Kinase
J. Biol. Chem., January 16, 2004; 279(3): 1713 - 1719.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. J. Povsic, T. A. Kohout, and R. J. Lefkowitz
{beta}-Arrestin1 Mediates Insulin-like Growth Factor 1 (IGF-1) Activation of Phosphatidylinositol 3-Kinase (PI3K) and Anti-apoptosis
J. Biol. Chem., December 19, 2003; 278(51): 51334 - 51339.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. A. Cunningham, Q. Zhu, T. G. Unterman, and J. M. Hammond
Follicle-Stimulating Hormone Promotes Nuclear Exclusion of the Forkhead Transcription Factor FoxO1a via Phosphatidylinositol 3-Kinase in Porcine Granulosa Cells
Endocrinology, December 1, 2003; 144(12): 5585 - 5594.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C.-D. Oh and J.-S. Chun
Signaling Mechanisms Leading to the Regulation of Differentiation and Apoptosis of Articular Chondrocytes by Insulin-like Growth Factor-1
J. Biol. Chem., September 19, 2003; 278(38): 36563 - 36571.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. Skalkidou, E. Petridou, E. Papathoma, H. Salvanos, S. Kedikoglou, G. Chrousos, and D. Trichopoulos
Determinants and Consequences of Major Insulin-like Growth Factor Components among Full-Term Healthy Neonates
Cancer Epidemiol. Biomarkers Prev., September 1, 2003; 12(9): 860 - 865.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. Seto-Young, J. Zajac, H.-C. Liu, Z. Rosenwaks, and L. Poretsky
The Role of Mitogen-Activated Protein Kinase in Insulin and Insulin-Like Growth Factor I (IGF-I) Signaling Cascades for Progesterone and IGF-Binding Protein-1 Production in Human Granulosa Cells
J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3385 - 3391.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
S. Wang, V. L. DeGroff, and S. K. Clinton
Tomato and Soy Polyphenols Reduce Insulin-Like Growth Factor-I-Stimulated Rat Prostate Cancer Cell Proliferation and Apoptotic Resistance In Vitro via Inhibition of Intracellular Signaling Pathways Involving Tyrosine Kinase
J. Nutr., July 1, 2003; 133(7): 2367 - 2376.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
C. S. Bickel, J. M. Slade, F. Haddad, G. R. Adams, and G. A. Dudley
Acute molecular responses of skeletal muscle to resistance exercise in able-bodied and spinal cord-injured subjects
J Appl Physiol, June 1, 2003; 94(6): 2255 - 2262.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
Z.-Y. Wang, Q. Zhang, J. Wilson, M. Z. Ratajczak, and M. A. Wasik
Detection of Protein Tyrosine-Kinase (PTK) Gene Expression Pattern in Normal and Malignant T Lymphocytes by Combined PTK-Specific Polymerase Chain Reaction and Parallel Denaturing Gradient Gel Electrophoresis
J. Mol. Diagn., May 1, 2003; 5(2): 113 - 120.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Tang, D. Zhang, L. Fallavollita, and P. Brodt
Vascular Endothelial Growth Factor C Expression and Lymph Node Metastasis Are Regulated by the Type I Insulin-like Growth Factor Receptor
Cancer Res., March 15, 2003; 63(6): 1166 - 1171.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Fukuda, K. Hirota, F. Fan, Y. D. Jung, L. M. Ellis, and G. L. Semenza
Insulin-like Growth Factor 1 Induces Hypoxia-inducible Factor 1-mediated Vascular Endothelial Growth Factor Expression, Which is Dependent on MAP Kinase and Phosphatidylinositol 3-Kinase Signaling in Colon Cancer Cells
J. Biol. Chem., October 4, 2002; 277(41): 38205 - 38211.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
G. R. Adams
Exercise Effects on Muscle Insulin Signaling and Action: Invited Review: Autocrine/paracrine IGF-I and skeletal muscle adaptation
J Appl Physiol, September 1, 2002; 93(3): 1159 - 1167.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
S. Oldham, H. Stocker, M. Laffargue, F. Wittwer, M. Wymann, and E. Hafen
The Drosophila insulin/IGF receptor controls growth and size by modulating PtdInsP3 levels
Development, September 1, 2002; 129(17): 4103 - 4109.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Prisco, F. Santini, R. Baffa, M. Liu, R. Drakas, A. Wu, and R. Baserga
Nuclear Translocation of Insulin Receptor Substrate-1 by the Simian Virus 40 T Antigen and the Activated Type 1 Insulin-like Growth Factor Receptor
J. Biol. Chem., August 23, 2002; 277(35): 32078 - 32085.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W.-H. Shen, J.-H. Zhou, S. R. Broussard, G. G. Freund, R. Dantzer, and K. W. Kelley
Proinflammatory Cytokines Block Growth of Breast Cancer Cells by Impairing Signals from a Growth Factor Receptor
Cancer Res., August 15, 2002; 62(16): 4746 - 4756.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Tanno, A. Negroni, R. Vitali, M. C. Pirozzoli, V. Cesi, C. Mancini, B. Calabretta, and G. Raschella
Expression of Insulin-like Growth Factor-binding Protein 5 in Neuroblastoma Cells Is Regulated at the Transcriptional Level by c-Myb and B-Myb via Direct and Indirect Mechanisms
J. Biol. Chem., June 21, 2002; 277(26): 23172 - 23180.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Ishii, A. Inanobe, and Y. Kurachi
PIP3 inhibition of RGS protein and its reversal by Ca2+/calmodulin mediate voltage-dependent control of the G protein cycle in a cardiac K+ channel
PNAS, April 2, 2002; 99(7): 4325 - 4330.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Navarro, B. Valentinis, B. Belletti, G. Romano, K. Reiss, and R. Baserga
Regulation of Id2 Gene Expression by the Type 1 IGF Receptor and the Insulin Receptor Substrate-1
Endocrinology, December 1, 2001; 142(12): 5149 - 5157.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Ishii, A. Inanobe, and Y. Kurachi
PIP3 inhibition of RGS protein and its reversal by Ca2+/calmodulin mediate voltage-dependent control of the G protein cycle in a cardiac K+ channel
PNAS, April 2, 2002; 99(7): 4325 - 4330.
[Abstract] [Full Text]